source
- Vaccine makers say splitting MMR vaccine is impractical despite presidential directiveVaccine manufacturers responded to a recent order from President Donald Trump to separate the combined measles, mumps and rubella (MMR) vaccine, noting that while the concept is theoretically possi…
- Hemab Therapeutics IPO raises $301.5M, stock triples and funds runway to 2029Hemab Therapeutics completed an upsized $301.5 million IPO in May, boosting total proceeds to $346.7 million. The offering helped the company’s share price climb from $18 at debut to $53.48 by mid‑…